Veterinary Drug terms — page 6 | HESTIA Glossary

Browse all 1,061 veterinary drug terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.

Carnosine N-beta-Alanyl-L-histidine; L-Carnosine; Carnosine; 305-84-0; beta-Alanyl-L-histidine; Karnozin; Karnozzn; Ignotine; Nalpha-(beta-alanyl)-L-histidine; L-Ignotine; N-2-M; UNII-8HO6PVN24W; L-Histidine, beta-alanyl-; L-HISTIDINE, N-beta-ALANYL-; NSC 524045; BRN 0087671; 8HO6PVN24W; CHEBI:15727; L-Histidine, N-.beta.-alanyl-; CQOVPNPJLQNMDC-ZETCQYMHSA-N; Polaprezinc; MFCD00005207; L-Carnosine, 98%; (2S)-2-(3-aminopropanamido)-3-(1H-imidazol-4-yl)propanoic acid; N-beta-alanyl-L-histidine; (2S)-2-(3-aminopropanoylamino)-3-imidazol-4-ylpropanoic acid; EINECS 206-169-9; (2~{S})-2-(3-azanylpropanoylamino)-3-(1~{H}-imidazol-4-yl)propanoic acid; beta-Alanylhistidine; .beta.-Alanyl-L-histidine; Z 103; Z-103; Sevitin; betaAla-His; b-Alanylhistidine; beta-Ala-His-OH; PubChem6017; beta-alanyl-l-histidin; .beta.-Alanylhistidine; Spectrum_001178; N-b-alanyl-L-Histidine; SpecPlus_000374; Spectrum2_000454; Spectrum3_001212; Spectrum4_001673; Spectrum5_000605; 3-aminopropionyl-histidine; bmse000246; bmse001002; C00386; N-(b-Alanyl)-L-histidine; SCHEMBL33769; BSPBio_002624; KBioGR_002225; KBioSS_001658; 4-25-00-04381 (Beilstein Handbook Reference); KSC911I2F; DivK1c_006470; SPECTRUM1500944; N-(3-Aminopropanoyl)histidine; SPBio_000528; CHEMBL242948; GTPL4559; CTK8B1422; KBio1_001414; KBio2_001658; KBio2_004226; KBio2_006794; KBio3_002124; DTXSID80879594; L-Carnosine, ~99%, crystalline; TNP00340; ZINC2040854; N(alpha)-(beta-alanyl)-L-histidine; ANW-26923; CCG-38696; SBB003316; STL466172; AKOS010421481; AKOS015963345; CS-W014210; DB11695; HY-W013494; MCULE-5739145561; RTR-013124; SDCCGMLS-0066726.P001; NCGC00017390-01; NCGC00017390-02; NCGC00142487-01; AC-17084; AC-19690; AS-12570; ST057076; TR-013124; A0222; FT-0631923; L-Carnosine, Vetec(TM) reagent grade, 98%; S5226; ST24030818; 305C840; Q413822; SR-05000002473; SR-05000002473-1; (2S)-2-(3-aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid; (S)-2-(3-aminopropanamido)-3-(1H-imidazol-4-yl)propanoic acid; (S,Z)-2-((3-amino-1-hydroxypropylidene)amino)-3-(1H-imidazol-5-yl)propanoic acid; 8V0; Ignotine; N-beta-alanyl-L-histidine; carnosine zwitterion; CHEBI:57485; N(alpha)-(beta-alaniniumyl)-L-histidinate; (2S)-2-[(3-azaniumylpropanoyl)amino]-3-(1H-imidazol-4-yl)propanoate; Carnosine; N-2-M
Carprofen 6-Chloro-alpha-methyl-9H-carbazole-2-acetic acid; Carprofen; C 5720
Castanospermine (1S,6S,7R,8R,8aR)-Octahydro-1,6,7,8-indolizinetetrol; Castanospermine; Castinospermine
Catechol 1,2-Benzenediol; pyrocatechol; catechol; 120-80-9; 1,2-dihydroxybenzene; 1,2-benzenediol; benzene-1,2-diol; pyrocatechin; 2-hydroxyphenol; o-Benzenediol; o-Dihydroxybenzene; Pyrocatechine; o-Dioxybenzene; o-Hydroquinone; o-Hydroxyphenol; o-Phenylenediol; Oxyphenic acid; Phthalhydroquinone; Fouramine PCH; benzenediol; Durafur developer C; Pelagol Grey C; Catechin (phenol); Fourrine 68; Benzene, o-dihydroxy-; Catechol (phenol); o-Diphenol; ortho-Hydroxyphenol; Pyrokatechin; Pyrokatechol; Katechol; ortho-Dihydroxybenzene; C.I. Oxidation Base 26; ortho-Benzenediol; ortho-Dioxybenzene; ortho-Hydroquinone; Katechol [Czech]; ortho-Phenylenediol; Pyrocatechinic acid; NCI-C55856; Pyrokatechin [Czech]; Pyrokatechol [Czech]; CI Oxidation Base 26; UNII-LF3AJ089DQ; NSC 1573; C.I. 76500; CCRIS 741; Catechol-pyrocatechol; HSDB 1436; YCIMNLLNPGFGHC-UHFFFAOYSA-N; EINECS 204-427-5; BRN 0471401; LF3AJ089DQ; CI 76500; AI3-03995; CHEMBL280998; DTXSID3020257; CHEBI:18135; MFCD00002188; 12385-08-9; CAQ; Catechol, 99+%; DSSTox_CID_257; DSSTox_RID_75468; DSSTox_GSID_20257; Phthalic alcohol; CAS-120-80-9; SMR000326660; Benzcatechin; Oxyphenate; Kachin; ortho-diphenol; benzene diol; ortho-Quinol; o Dihydroxybenzene; 4oow; alpha-hydroxyphenol; 1,2-benzenedio; o-dihydroxy-benzene; phenol derivative, 2; 3fw4; 4k7i; ACMC-1BTYG; Pyrocatechol, >=99%; Lopac-C-9510; WLN: QR BQ; bmse000385; EC 204-427-5; 1,2-Dihydroxybenzene, XI; 1,2-Benzenediol; Catechol; Lopac0_000280; SCHEMBL18351; KSC177E7T; MLS002153385; MLS002303022; BIDD:ER0327; Pyrocatechinic acidPyrocatechol; Pyrocatechol, p.a., 99.0%; BDBM26188; CTK0H7279; Durafur Developer CFouramine PCH; NSC1573; Benzene-1,2-diol (Pyrocatechol); HMS2233A17; HMS3260H22; HMS3373K16; KS-000000NB; NSC-1573; Tox21_202317; Tox21_300153; Tox21_500280; ANW-17534; BBL002408; LS-637; s6305; SBB040792; STK398651; ZINC13512214; AKOS000119002; CCG-204375; DB02232; LP00280; MCULE-9007211544; RTR-003436; SDCCGSBI-0050268.P002; TRA0043461; Catechol 100 microg/mL in Acetonitrile; NCGC00015283-01; NCGC00015283-02; NCGC00015283-03; NCGC00015283-04; NCGC00015283-05; NCGC00015283-06; NCGC00015283-07; NCGC00015283-08; NCGC00091262-01; NCGC00091262-02; NCGC00091262-03; NCGC00253952-01; NCGC00259866-01; NCGC00260965-01; BP-21156; SC-19023; AB1002105; Catechol (Pyrocatechol; Benzene-1,2-diol); DB-003770; ST2407554; TR-003436; EU-0100280; FT-0606411; P0317; P0567; ST50214346; T7344; Pyrocatechol; 1,2-Dihydroxybenzene; Catechol; 3437-EP2298767A1; 3437-EP2301934A1; 3437-EP2305633A1; 3437-EP2314587A1; C 9510; C00090; C01785; C15571; 1,2-Dihydroxybenzene, ReagentPlus(R), >=99%; 28696-EP2314579A1; Pyrocatechol, purified by sublimation, >=99.5%; A804599; AB-131/40235236; Q282440; SR-01000075791; SR-01000075791-1; W-109068; F0001-0332; Pyrocatechol, certified reference material, TraceCERT(R); Z1262246103; InChI=1/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8; Pyrocatechol, plant cell culture tested, BioReagent, >=99%, powder; 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-,(2R-trans)-; 19481-10-8; C.I. 76500
Cefaclor (6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefaclor [INN]; S 6472
Cefalonium 4-Carbamoyl-1-[[2-carboxy-8-oxo-7-[2-(2-thienyl)acetamido]-5-thia-1-azabicyclo[4-2-0]oct-2-en-3-yl]methyl]pyridinium, Hydroxide, Inner salt; Cephalonium; BRN 4169337
Cefazolin (6R,7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefazolin; BRN 4169371
Cefotaxime (6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefotaxime; Cefotaxima [INN-Spanish]
Cefoxitin (6R,7S)-3-[[(Aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefoxitin; Cefoxitin
Ceftazidime 1-[[(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium inner salt; Ceftazidime [INN]; BRN 4344904
Ceftizoxime (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Ceftizoxime; Ceftizoxima [INN-Spanish]
Ceftriaxone (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Ceftriaxone; Ceftriaxona [INN-Spanish]
Celecoxib 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-benzenesulfonamide; Celecoxib; Celebrex
Celiprolol UREA, N'-[3-ACETYL-4-[3-[(1,1-DIMETHYLETHYL)AMIN; Celiprolol; N'-(3-Acetyl-4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-N,N-diethylurea
Cephalexin (6R,7R)-7-[[(2R)-Aminophenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cephalexin; S 6437
Cephaloridine (6R-trans)-1-[[2-Carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium, Hydrochloride, Inner salt; Cephaloridine; Aliporina
Cephalosporins (1st and 2nd generation) Cephamycin; Cefacetrile; Cefaclor; Cefadroxil; Cefalexin; Cefalonium; Cefaloridine; Cefalotin; Cefalotin; Cefamandole; Cefapirin; Cefatrizine; Cefazedone; Cefazolin; Cefbuperazone; Cefmetazole; Cefminox; Cefonicid; Ceforanide; Cefotetan; Cefotiam; Cefoxitin; Cefprozil; Cefradine; Cefroxadine; Ceftezole; Cefuroxime; Flomoxef; Loracarbef
Cephalosporins (3rd, 4th, and 5th generation) Cefcapene; Cefdinir; Cefditoren; Cefepime; Cefetamet; Cefixime; Cefmenoxime; Cefodizime; Cefoperazone; Cerfoperazone-Sulbactam; Cefoselis; Cefotaxime; Cefovecin; Cefozopran; Cefpiramide; Cefpirome; Cefpodoxime; Cefquinome; Cefsulodin; Ceftaroline Fosamil; Ceftazidime; Ceftazidime-Avibactum; Ceftibuten; Ceftiofur; Ceftizoxime; Ceftobiprole; Ceftobiprole; Ceftolozane; Ceftriaxone; Ceftriazone-Sulbactam; Latamoxef; Tazobactam
Cephalothin (6R,7R)-3-[(Acetyloxy)methyl]-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cephalothin; 6R-trans-3-((Acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-carboxylic acid
Cephapirin sodium 3-[(Acetyloxy)methyl]-8-oxo-7-[[(4-pyridinylthio)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt (1:1); Cephapirin sodium [USAN:USP]; Ambrocef
Cetrorelix N-Acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N5-(aminocarbonyl)-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide; Cetrorelix; Cetrorelixum [INN-Latin]
Chenodeoxycholic acid (3alpha,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid; Chenodeoxycholic acid; Acide chenodeoxycholique [INN-French]
Chloral Trichloroacetaldehyde; CHLORAL; Trichloroacetaldehyde; 2,2,2-Trichloroacetaldehyde; 75-87-6; Acetaldehyde, trichloro-; Trichloroethanal; Anhydrous chloral; Grasex; Cloralio; TRI-CHLORO-ACETALDEHYDE; RCRA waste number U034; Cloralio [Italian]; Chloral (IUPAC); UNII-FLI06WS32H; CCRIS 852; Trichloro-Acetaldehyde; HSDB 2557; Acetaldehyde, 2,2,2-trichloro-; 2,2,2-Trichloroethanal; EINECS 200-911-5; UN2075; RCRA waste no. U034; BRN 0506422; FLI06WS32H; Acetaldehyde,2,2,2-trichloro-; DTXSID7024744; CHEBI:48814; HFFLGKNGCAIQMO-UHFFFAOYSA-N; Chloral anhydrous; Trichloracetaldehyde; Trichloroacetaldehyd; Chloral, Anhydrous; CCl3CHO; SCHEMBL75613; 4-01-00-03142 (Beilstein Handbook Reference); Chloral, anhydrous, inhibited; UN 2075 (Salt/Mix); CHEMBL27551; CTK5E2129; KS-00000X7B; STR00138; ZINC3875479; BBL011380; STL146480; AKOS000119168; DB02650; LS-1678; SC-81468; DB-007348; TC-030693; FT-0080782; C14866; InChI=1/C2HCl3O/c3-2(4,5)1-6/h1; Chloral, anhydrous, inhibited [UN2075] [Poison]; Q422755; Chloral, anhydrous, inhibited [UN2075] [Poison]; W-109044; CHLORAL (SEE ALSO CHLORAL HYDRATE 302-17-0); F2191-0156; chloral; acetaldehyde, 2,2,2-trichloro-; trichloroethanal; trichloroacetaldehyde; acetaldehyde, trichloro-; chloral, anhydrous; Chloral; 4-01-00-03142 (Beilstein Handbook Reference)
Chlorambucil 4-[Bis(2-chloroethyl)amino]benzenbutanone acid; Chlorambucil; 4-14-00-01715 (Beilstein Handbook Reference)
Chloramphenicol 2,2-Dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide; chloramphenicol; 56-75-7; Chloromycetin; Chlornitromycin; Levomycetin; Halomycetin; Levomicetina; Chlorocid; Globenicol; Chloroamphenicol; Alficetyn; Chloramex; Chlorocol; Detreomycin; Oleomycetin; Fenicol; Amphenicol; Aquamycetin; Chloramficin; Chloramfilin; Cloramicol; D-Chloramphenicol; Enteromycetin; Juvamycetin; Leukomycin; Sificetina; Chloronitrin; Ciplamycetin; Detreomycine; Dextromycetin; Intramycetin; Laevomycetinum; Levomitsetin; Mediamycetine; Micochlorine; Novophenicol; Stanomycetin; Amphicol; Amseclor; Anacetin; Austracil; Austracol; Biocetin; Biophenicol; Chemicetin; Chemicetina; Chlomycol; Chloramsaar; Chlorasol; Chloricol; Chlorocaps; Chlorocide; Chloroptic; Chlorovules; Cidocetine; Cloramficin; Cloramidina; Clorocyn; Cloromisan; Clorosintex; Comycetin; Cylphenicol; Doctamicina; Econochlor; Embacetin; Erbaplast; Farmicetina; Hortfenicol; Isicetin; Ismicetina; Isophenicol; Kemicetina; Kemicetine; Leukomyan; Loromisin; Mastiphen; Medichol; Micloretin; Micoclorina; Microcetina; Novomycetin; Ophthochlor; Rivomycin; Ambofen; Catilan; Chlomin; Desphen; Emetren; Enicol; Ertilen; Glorous; Kamaver; Klorita; Mychel; Isopto fenicol; Chlora-tabs; Chlorocidin C; Chloramphenicolum; Chloroject L; Normimycin V; Chlorocid S; Klorocid S; Mychel-Vet; Chloramfenikol; Cloramfenicol; Novochlorocap; Sintomicetina; Synthomycetin; Chloromax; Oftalent; Otachron; Pantovernil; Pentamycetin; Quemicetina; Romphenil; Ronphenil; Septicol; Chloro-25 vetag; Mycinol; Opclor; Otophen; Paraxin; Sintomicetine R; Sno-Phenicol; Chlorocidin C tetran; Cloroamfenicolo; D-(-)-Chloramphenicol; Chloromycetny; Synthomycetine; Treomicetina; Chlorofair; Optomycin; Syntomycin; Tevcocin; Tifomycine; Unimycetin; Veticol; Viceton; Tiromycetin; Cloramfen; Leukamycin; Loromisan; Tifomycin; CAF (pharmaceutical); Ak-chlor; Chloramfenikol [Czech]; Chloromycetny [Polish]; D-(-)-threo-Chloramphenicol; Cloramfenicolo [DCIT]; Tega-Cetin; Chlorbiotic (Veterinary); I 337A; Cloroamfenicolo [Italian]; Chloramphenicol crystalline; Elase-Chloromycetin; Chloramphenicol, d-; U-6062; NCI-C55709; NSC 3069; Cloramfenicol [INN-Spanish]; Chloramphenicolum [INN-Latin]; D-threo-Chloramphenicol; 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide; D(-)-threo-Chloramphenicol; D-(-)-threo-1-p-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol; CAF; C11H12Cl2N2O5; CCRIS 3922; UNII-66974FR9Q1; CHEBI:17698; HSDB 3027; NSC3069; 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide; D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenylethyl)acetamide; EINECS 200-287-4; NSC 16331; CAM; D-(-)-threo-1-p-Nitrophenyl-2-dichloracetamido-1,3-propanediol; BRN 2225532; AI3-25003; Chloramphenicol (Chloromycetin); Cloramfenicolo; D-(-)-threo-2-Dichloroacetamido-1-p-nitrophenyl-1,3-propanediol; WIIZWVCIJKGZOK-RKDXNWHRSA-N; D-(-)-threo-1-(4-Nitrophenyl)-2-dichloroacetamido-1,3-propanediol; D-threo-(1R,2R)-1-p-Nitrophenyl-2-dichloroacetamido-1,3-propanediol; NSC-3069; MFCD00078159; Acetamide, 2,2-dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl)-, (R-(R*,R*))-; Acetamide, 2,2-dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-, [R-(R*,R*)]-; 66974FR9Q1; Chloramphenicol, 98%; NCGC00091011-05; Cloranfenicol; Kloramfenikol; DSSTox_CID_265; D-threo-N-(1,1'-Dihydroxy-1-p-nitrophenylisopropyl)dichloroacetamide; 2,2-Dichloro-N-((1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)acetamide; 2,2-Dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)-2-propyl]acetamide; 2,2-Dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide; DSSTox_RID_75473; DSSTox_GSID_20265; Gloveticol; Mycochlorin; Ocuphenicol; Sintomicetin; Tyfomycine; Chlorocin; Halcetin; Levocin; Levoplast; Levosin; Levovetin; Myclocin; Soluthor; Chloroptic S.O.P.; Chemiceticol; Cloramical; Cloromissan; Duphenicol; Interomycetine; Intramyctin; Loromicetina; Ophtochlor; Synthomycine; Chlorsig; Ronfenil; Tevcosin; Myscel; Opelor; D(-)-threo-2-Dichloroacetamido-1-p-nitrophenyl-1,3-propanediol; Chlormycetin R; F armicetina; Ch loramex; Sno Phenicol; D-(-)-threo-2-Dichloroacetamido-1-(4-nitrophenyl)-1,3-propanediol; Vice ton; (-)-chloramphenicol; Tea-Cetin; Acetamide, 2,2-dichloro-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl)-; D-threo-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide; Econochlor (TN); N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-2,2-dichloroace tamide; Amphicol (TN); Ophthocort (Salt/Mix); Acetamide, 2,2-dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl)-, (theta-(theta,theta))-; Acetamide, 2,2-dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)-, D-(-)-threo-; ACETAMIDE, 2,2-DICHLORO-N-[(1R,2R)-2-HYDROXY-1-(HYDROXYMETHYL)-2-(4-NITROPHENYL)ETHYL]-; SMR000471851; Chloromyxin (Salt/Mix); Chloromycetin (TN); Chloramphenicol [INN:BAN:JAN]; SR-01000761450; CHLOROPTIC S.O.P; Elase-Chloromycetin (Salt/Mix); chioramphenicol; C.A.F; Chloramphenicole; CAS-56-75-7; NCGC00094620-01; Thiamphenicol,(S); D-(-)-threo-2,2-Dichloro-N-(.beta.-hydroxy-.alpha.-(hydroxymethyl))-p-nitrophenethylacetamide; D-(-)-threo-2,2-Dichloro-N-[.beta.-hydroxy-.alpha.-(hydroxymethyl)]-p-nitrophenethylacetamide; Chloramphenicol [USP:INN:BAN:JAN]; Chloramphenicol,(S); PubChem20321; Prestwick3_000031; CHEMBL130; Epitope ID:114066; SCHEMBL16111; BSPBio_000121; WLN: WNR DYQY1QMVYGG; 4-13-00-02742 (Beilstein Handbook Reference); MLS001055372; MLS001066397; MLS001332385; MLS001332386; MLS002222155; ARONIS23913; BIDD:GT0145; DivK1c_000544; BPBio1_000135; D-(-)-threo-1-(p-Nitrophenyl)-2-(dichloroacetylamino)-1,3-propanediol; D-(-)-threo-N-Dichloroacetyl-1-p-nitrophenyl-2-amino-1,3-propanediol; DTXSID7020265; BDBM23447; Chloramphenicol, gamma-irradiated; CTK4B4374; HMS501L06; KBio1_000544; KS-00000XTX; BBC/192; BIC0113; D(-)-threo-2-dichloroacetamido-1-p-nitrophenyl-propanediol; NINDS_000544; ZX-AFC000642; Chloramphenicol (JP17/USP/INN); D(-)-threo-2-dichloroacetamido-1-p-nitrophen yl-propanediol; HMS2090M15; HMS2095G03; HMS2269N06; HMS3712G03; ZINC113382; Chloramphenicol, >=98% (HPLC); Acetamide, 2,2-dichloro-N-(.beta.-hydroxy-.alpha.-(hydroxymethyl)-p-nitrophenethyl)-, D-(-)-threo-; Acetamide, 2,2-dichloro-N-[.beta.-hydroxy-.alpha.-(hydroxymethyl)-p-nitrophenethyl]-, D-threo-(-)-; BCP12150; D-(-)-threo-2,2-Dichloro-N-(.beta.-hydroxy-.alpha.-(hydroxymethyl)-p-nitrophenyl-ethyl)acetamide; D-threo-N-Dichloroacetyl-1-p-nitrophenyl-2-amino-1,3-propanediol; HY-B0239; RKL10087; Tox21_111306; Tox21_400061; LS-225; s1677; SBB057728; AKOS005111001; AB02994; CCG-220031; CS-2207; DB00446; MCULE-7778960570; IDI1_000544; KS-000048O2; SMP1_000065; NCGC00091011-01; NCGC00091011-02; NCGC00091011-03; NCGC00091011-04; NCGC00091011-06; NCGC00091011-08; NCGC00091011-09; AK174225; AS-14683; CC-25647; CPD000471851; M163; NCI60_002620; SAM002589931; SC-18476; ST024743; AB0015087; AB1009524; Chloramphenicol, puriss., 98.0-102.0%; AB00374860; Chloramphenicol, tested according to Ph.Eur.; FT-0602995; SW198497-2; Chloramphenicol 100 microg/mL in Acetonitrile; C-3307; C00918; Chloramphenicol 100 microg/mL in Ethyl acetate; D00104; W-2830; AB00374860-13; AB00374860-14; AB00374860_15; Chloramphenicol, meets USP testing specifications; C-19742; Q274515; Chloramphenicol, VETRANAL(TM), analytical standard; SR-01000761450-2; SR-01000761450-3; SR-01000761450-5; BRD-K08111712-001-02-7; BRD-K08111712-001-16-7; Chloramphenicol, Antibiotic for Culture Media Use Only; Chloramphenicol, BioReagent, suitable for plant cell culture; Chloramphenicol, certified reference material, TraceCERT(R); Chloramphenicol, British Pharmacopoeia (BP) Reference Standard; Chloramphenicol, European Pharmacopoeia (EP) Reference Standard; Chloramphenicol, United States Pharmacopeia (USP) Reference Standard; D-(-)-threo-1-(p-nitrophenyl)-2-dichloroacetamido-1,3-propanediol; D-threo-1-(p-Nitrophenyl)-2-(dichloroacetylamino)-1,3-propanediol; D-threo-N-dichloroacetyl-1-p-nitrophenyl-2-amino-1,3-propane-diol; CHLORAMPHENICOL (SEE ALSO CHLORAMPHENICOL NA SUCCINATE 982-57-0); D-( -)-threo-1-(p-nitrophenyl)-2-dichloroacetamido-1,3-propanediol; Acetamide,2-dichloro-N-[.beta.-hydroxy-.alpha.-(hydroxymethyl)-p-nitrophenethyl]; Chloramphenicol, Biotechnology Performance Certified, suitable for plant cell culture; D-(-)-2,2-Dichloro-N-(.beta.-hydroxy-.alpha.-(hydroxymethyl)-p-nitrophenyl-ethyl)acetamide; D-(-)-threo-2,2-Dichloro-N-[beta-hydroxy-alpha-(hydroxy-methyl)-p-nitrophenethyl]acetamide; D-threo-2,2-Dichloro-N-[beta-hydroxy-alpha-(hydroxymethyl)-4-nitrophenethyl]acetamide; 2,2-Dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4-(hydroxy(oxido)amino)phenyl)ethyl)acetamide, (1R, 2R)-; 2787-09-9; Acetamide, 2,2-dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl)-, (R*,R*)-(+-)-; Acetamide, 2,2-dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)-,D-(-)-threo-; Acetamide, 2,2-dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4- nitrophenyl)ethyl]-, [R-(R*,R*)]-; Acetamide,2-dichloro-N-[.beta.-hydroxy-.alpha.-(hydroxymethyl)-p-nitrophenethyl]-, D-threo-(-)-; Acetamide,2-dichloro-N-[.beta.-hydroxy-.alpha.-(hydroxymethyl)-p-nitrophenethyl]-,D-(-)-threo-; Acetamide,2-dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-, [R-(R*,R*)]-; Chloramphenicol 10 microg/mL in Acetonitrile. Short expiry date due to chemical nature of component(s); D-(-)-threo-2,2-Dichloro-N-[beta-hydroxy-alpha-(hydroxymethyl)-beta-(4-nitrophenyl)ethyl]acetamide; D-(-)-threo-alpha, alpha-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide; Chloramphenicol; I 337A
Chlorcyclizine 1-[(4-Chlorophenyl)phenylmethyl]-4-methylpiperazine; chlorcyclizine; Chlorcycline; Chlorocycline; Alergicide; Perazyl; Chlorocyclizine; Histantine; Histantin; Trihistan; Di-paralen; Histachlorazene; Diparalene; 82-93-9; Compound 47-282; Piparalene; Clorciclizina [DCIT]; 1-(4-Chlorobenzhydryl)-4-methylpiperazine; Chlorcyclizine [INN:BAN]; N-Methyl-N'-(4-chlorobenzhydryl)piperazine; NSC 25246; Chlorcyclizinum [INN-Latin]; Clorciclizinio [INN-Spanish]; Di-Paralene; HSDB 3217; EINECS 201-446-0; BRN 0272719; 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine; CHEMBL22150; Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-; Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-methyl-; NSC25246; 1-(p-Chloro-alpha-phenylbenzyl)-4-methylpiperazine; 1-((4-Chlorophenyl)phenylmethyl)-4-methylpiperazine; 1-[(4-Chlorophenyl)phenylmethyl]-4-methylpiperazine; Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-methyl-; 1-(p-Chloro-.alpha.-phenylbenzyl)-4-methylpiperazine; Piperazine, 1-(p-chloro-.alpha.-phenylbenzyl)-4-methyl-; Chlorcyclizinum; Clorciclizina; Clorciclizinio; Prestwick0_000706; Prestwick1_000706; Prestwick2_000706; Prestwick3_000706; SCHEMBL4383; Oprea1_854942; BSPBio_000891; DivK1c_000210; SPBio_002812; BPBio1_000981; DTXSID9048011; CHEBI:94402; KBio1_000210; NINDS_000210; WFNAKBGANONZEQ-UHFFFAOYSA-N; Chlorcyclizine, >=98% (HPLC); BDBM50329371; NSC-25246; PDSP1_000150; PDSP2_000149; AKOS015962157; API0008666; DB08936; MCULE-4720374498; WLN: T6N DNTJ AYR&R DG& D1; IDI1_000210; NCGC00179384-01; AC-15952; SBI-0206679.P002; LS-111205; AB00053788; AB00053788_09; Q2393323; BRD-A57133233-003-03-7; BRD-A57133233-003-06-0; 1-((4-chlorophenyl)(phenyl)methyl)-4-methylpiperazine; 1-[(4-chlorophenyl)-phenyl-methyl]-4-methyl-piperazine; 1-[(4-Chloro-phenyl)-phenyl-methyl]-4-methyl-piperazine; Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl- (9CI); Chlorcyclizine; 5-23-01-00235 (Beilstein Handbook Reference)
Chlorhexidine N,N''-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide; chlorhexidine; 55-56-1; Rotersept; Tubulicid; Fimeil; Hexadol; Soretol; Chlorhexidin; Chlorhexidinum; Sterilon; Nolvasan; Cloresidina [DCIT]; Chlorhexidin [Czech]; Chlorhexidinum [INN-Latin]; Clorhexidina [INN-Spanish]; Hibistat; Chlorhexidine [INN:BAN]; Chlorohexidine; 1,6-Bis(p-chlorophenyldiguanido)hexane; 1,6-Di(4'-chlorophenyldiguanido)hexane; UNII-R4KO0DY52L; 1,6-Bis(5-(p-chlorophenyl)biguandino)hexane; Exidine; CCRIS 9230; C22H30Cl2N10; 1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide); 1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide); HSDB 7196; 2,4,11,13-Tetraazatetradecanediimidamide, N,N''-bis(4-chlorophenyl)-3,12-diimino-; EINECS 200-238-7; CHEMBL790; BRN 2826432; R4KO0DY52L; 1,6-Di(N-p-chlorophenyldiguanido)hexane; MLS001332388; CHEBI:3614; Cloresidina; Clorhexidina; Biguanide, 1,1'-hexamethylenebis(5-(p-chlorophenyl)-; Chlorhexidine, 98%; CAS-55-56-1; NCGC00016246-03; Novalsan; SMR000857146; Sterido; Savlon babycare; Sebidin A; N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]; 56-95-1; DSSTox_CID_13314; DSSTox_RID_79062; N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide; DSSTox_GSID_33314; Q-200828; Chlorhexidine dihydrochloride; MLS001304094; 2,4,11,13-Tetraazatetradecanediimidamide, N,N'-bis(4-chlorophenyl)-3,12-diimino-; N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide; 1-(4-chlorophenyl)-3-[N-[6-[[N-[N-(4-chlorophenyl)carbamimidoyl]carbamimidoyl]amino]hexyl]carbamimidoyl]guanidine; N-(4-chlorophenyl)-1-3-(6-{N-[3-(4-chlorophenyl)carbamimidamidomethanimidoyl]amino}hexyl)carbamimidamidomethanimidamide; Chlorhexidine (INN); Merfen-incolore (TN); MK-412A; SR-01000799135; Nolvasan (*Diacetate*); 1,1'-Hexamethylenebis(5-[p-chlorophenyl]biguanide); SMR000718621; Lisium (*Dihydrochloride*); GHXZTYHSJHQHIJ-UHFFFAOYSA-N; Dentisept [veterinary] (TN); 1,6-Bis(N5-[p-chlorophenyl]-N1-biguanido)hexane; Prestwick_53; Chlorhexidine (1); Hibidil (Salt/Mix); Hibisol (Salt/Mix); Chlorhexidine diacetate salt hydrate; Hibitane (Salt/Mix); Hibiscrub (Salt/Mix); Hibispray (Salt/Mix); NSC526936; Spectrum_000237; Savloclens (Salt/Mix); Prestwick0_000143; Prestwick1_000143; Prestwick2_000143; Prestwick3_000143; Spectrum2_000135; Spectrum3_000339; Spectrum4_000277; Spectrum5_001322; chlorhexidine diacetate salt; EC 200-238-7; SCHEMBL3984; Chlorhexidine, >=99.5%; BSPBio_000246; BSPBio_001977; KBioGR_000774; KBioSS_000717; 4-12-00-01201 (Beilstein Handbook Reference); MLS001332387; MLS002154209; DivK1c_000761; SPBio_000210; SPBio_002185; BPBio1_000272; DTXSID2033314; BDBM51937; BDBM64773; cid_9552079; KBio1_000761; KBio2_000717; KBio2_003285; KBio2_005853; KBio3_001197; 2,4,11,13-Tetraazatetradecanediimidamide, N1,N14-bis(4-chlorophenyl)-3,12-diimino-; cid_12303047; NINDS_000761; REGID_for_CID_9552079; BDBM152706; HMS1568M08; HMS2095M08; HMS2233B16; HMS3712M08; (1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine; HY-B1248; Tox21_110325; Tox21_201404; Tox21_303445; BDBM50170723; GA1676; MFCD00012532; s5397; SBB057564; STK089248; 1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]; AKOS005394319; Tox21_110325_1; CCG-220143; CS-4958; DB00878; EBD2224760; MCULE-4644073142; IDI1_000761; N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]; QTL1_000020; NCGC00016246-01; NCGC00016246-02; NCGC00016246-04; NCGC00016246-05; NCGC00016246-06; NCGC00016246-07; NCGC00016246-09; NCGC00016246-13; NCGC00091025-01; NCGC00091025-02; NCGC00091025-04; NCGC00247766-01; NCGC00257242-01; NCGC00258955-01; (1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine; AK173132; AS-12648; CC-25659; LS-43917; SC-17656; Chlorhexidine, purum, >=99.0% (HPLC); SBI-0051301.P003; AB1003159; AB00053427; C06902; D07668; AB00053427-24; AB00053427-28; AB00053427_29; 009C673; C-22973; SR-01000799135-5; 1,1''-Hexamethylene bis(5-(p-chlorophenyl)biguanide); BRD-K52256627-300-03-3; BRD-K52256627-300-05-8; SR-01000799135-10; SR-01000799135-11; Chlorhexidine, European Pharmacopoeia (EP) Reference Standard; 1,1'-(Hexane-1,6-diyl)bis[5-(4-chlorophenyl)biguanide] diacetate; Chlorhexidine, United States Pharmacopeia (USP) Reference Standard; Chlorhexidine, Pharmaceutical Secondary Standard; Certified Reference Material; N'',N''''''''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]; N,N''-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide; (1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylene]amino]methylene]amino]hexyl]-1-[amino-(4-chloroanilino)methylene]guanidine; hydrochloride; (1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine; hydrochloride; (1E)-2-[6-[[azanyl-[(E)-[azanyl-[(4-chlorophenyl)amino]methylidene]amino]methylidene]amino]hexyl]-1-[azanyl-[(4-chlorophenyl)amino]methylidene]guanidine; (1E)-2-[6-[[azanyl-[(E)-[azanyl-[(4-chlorophenyl)amino]methylidene]amino]methylidene]amino]hexyl]-1-[azanyl-[(4-chlorophenyl)amino]methylidene]guanidine; hydrochloride; {[(4-chlorophenyl)amino]iminomethyl}{[(6-{[({[(4-chlorophenyl)amino]iminomethy l}amino)iminomethyl]amino}hexyl)amino]iminomethyl}amine; 2-[amino-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexylimino]methyl]-1-(4-chlorophenyl)guanidine; 2-[amino-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexylimino]methyl]-1-(4-chlorophenyl)guanidine; hydrochloride; N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide; 4-12-00-01201 (Beilstein Handbook Reference)
Chlorhexidine diacetate N,N''-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide, Diacetate; N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca-nediimidamide, diacetate; 10,040 Diacetate
Chlorhexidine gluconate D-Gluconic acid compd. with N1,N4'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide (2:1); Chlorhexidine digluconate; Abacil
Chlormerodrin [3-[(Aminocarbonyl-kappaO)amino]-2-methoxypropyl-kappaC]chloromercury; Chlormerodrin; AI3-18000
Chlorotrianisene chlorotrianisene; 569-57-3; Chlortrianizen; Chlortrianisestrol; TACE; Chlorotrianisine; Chlorestrolo; Chlorotrianizen; Chlortrianisen; Chloortrianisestrol; Clorotrisin; Hormonisene; Khlortrianizen; Clorestrolo; Merbentul; Anisene; Metace; Rianil; Chlortrianisoestrolum; Chlortrianisene; Chlorotrisin; Tri-p-anisylchloroethylene; Chlortrianisenum; Tace-fn; Tris(p-methoxyphenyl)chloroethylene; Clorotrianiseno; Trianisestrol; Triagen; Chlorotrianisenum [INN-Latin]; Chlorotrianisenum; Tace (pharmaceutical); Clorotrianiseno [INN-Spanish]; Chlorotris(p-methoxyphenyl)ethylene; Clorotrianisene [DCIT]; NSC-10108; Ethylene, chlorotris(p-methoxyphenyl)-; CTA; CCRIS 4769; HSDB 3302; UNII-6V5034L121; EINECS 209-318-6; 1,1',1''-(1-Chloro-1-ethenyl-2-ylidene)-tris(4-methoxybenzene); Benzene, 1,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris(4-methoxy)-; BRN 1891845; Chlorotrianisene [Nonsteroidal oestrogens]; MLS000028625; CHEBI:3641; Clorotrianisene; NCGC00016511-02; CAS-569-57-3; SMR000058658; 1,1',1''-(2-chloroethene-1,1,2-triyl)tris(4-methoxybenzene); 1-[2-chloro-1,2-bis(4-methoxyphenyl)ethenyl]-4-methoxybenzene; Benzene, 1,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris[4-methoxy-; 6V5034L121; 1,1',1''-(2-chloroethene-1,1,2-triyl)tris[4-(methyloxy)benzene]; DSSTox_CID_1299; DSSTox_RID_76067; DSSTox_GSID_21299; 4,4',4''-(2-chloroethene-1,1,2-triyl)tris(methoxybenzene); Benzene, 1,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris(4-methoxy-; Benzene, 1,1',1'-(1-chloro-1-ethenyl-2-ylidene)tris(4-methoxy)-; Chlorotrianisene [INN:BAN]; Chlorotrianisene (INN); SR-01000721940; TACE (TN); Chlorotrianisene [USP:INN:BAN]; Prestwick_22; Spectrum_000136; Chlorotrianisene, ~95%; Opera_ID_1728; Prestwick0_000757; Prestwick1_000757; Prestwick2_000757; Prestwick3_000757; Spectrum2_000704; Spectrum3_000343; Spectrum4_000954; Spectrum5_000711; SCHEMBL8225; BSPBio_000774; BSPBio_002005; KBioGR_001568; KBioSS_000596; 4-06-00-07650 (Beilstein Handbook Reference); MLS002415722; SPECTRUM1500181; SPBio_000887; SPBio_002713; BPBio1_000852; GTPL7146; CHEMBL1200761; DTXSID1021299; KBio2_000596; KBio2_003164; KBio2_005732; KBio3_001225; BFPSDSIWYFKGBC-UHFFFAOYSA-N; HMS1570G16; HMS1920K17; HMS2091C20; HMS2097G16; HMS2230L03; HMS3371E11; HMS3714G16; BCP13708; HY-B2158; NSC10108; ZINC1530598; Tox21_110466; Tox21_202361; Tox21_302897; CCG-40079; LS-226; s4629; WLN: 1OR DYGUYR DO1&R DO1; AKOS015960863; Tox21_110466_1; API0001964; DB00269; NCGC00016511-01; NCGC00016511-03; NCGC00016511-04; NCGC00016511-05; NCGC00016511-08; NCGC00091333-01; NCGC00091333-02; NCGC00091333-03; NCGC00256381-01; NCGC00259910-01; AC-12512; SBI-0051309.P003; DB-052990; AB00051941; AK00618265; B5912; CS-0020308; FT-0632409; A16446; D00269; 162370-EP2280006A1; 162370-EP2281813A1; 569C573; C-50387; Q5103213; SR-01000721940-2; SR-01000721940-3; 1,1',1''(1-Chloro-1-ethenyl-2-ylidene)tris[4-methoxybenzene]; 1-[2-Chloro-1,2-bis(4-methoxyphenyl)vinyl]-4-methoxybenzene #; Benzene,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris[4-methoxy-; 4-06-00-07650 (Beilstein Handbook Reference)
Chloroxine 5,7-Dichloro-8-quinolinol; chloroxine; 5,7-Dichloroquinolin-8-ol; 773-76-2; 5,7-Dichloro-8-hydroxyquinoline; Chlorquinol; 5,7-Dichloro-8-quinolinol; Capitrol; Dichloroxin; Quixalin; Chloroxyquinoline; Dichloroquinolinol; Dikhloroskin; Clofuzid; Endiaron; Quinolor; Dichlorohydroxyquinoline; Chlofucid; Quesyl; 5,7-Dichlorooxine; 5,7-Dichloroxine; 5,7-Dichloro-8-oxyquinoline; 8-QUINOLINOL, 5,7-DICHLORO-; Chlorohydroxyquinoline; Chloroxine [USAN]; 5,7-Dichlor-8-hydroxychinolin; C9H5Cl2NO; NSC 3904; CHQ; UNII-2I8BD50I8B; CCRIS 5751; Capitrol Cream Shampoo; EINECS 212-258-3; BRN 0153606; 5,7-Dichlor-8-hydroxychinolin [German]; SQ 16401; 2I8BD50I8B; 5,7-Dichloro-8-hydroquinoline; CHEBI:59477; NSC3904; WDFKMLRRRCGAKS-UHFFFAOYSA-N; Chloroxine (USAN); AS-229; NCGC00095264-01; DSSTox_CID_2801; DSSTox_RID_76734; DSSTox_GSID_22801; dichloroquine; 5,7-Dichloro-8-hydroxyquinoline, 99%; CAS-773-76-2; SR-01000747474; 5,7-Dichloro-8-hydroxy-quinoline; Capitrol (TN); MFCD00006786; PubChem21919; Spectrum_001434; 5,7-Dichloro-8-oxine; Spectrum2_000687; Spectrum3_001156; Spectrum4_000744; Spectrum5_001444; 8-Quinolinol,7-dichloro-; ACMC-209p9h; cid_2722; SCHEMBL3350; Oprea1_486275; REGID_for_CID_2722; BSPBio_002711; KBioGR_001068; KBioSS_001914; 5-21-03-00286 (Beilstein Handbook Reference); KSC495K7R; MLS000681736; BIDD:GT0763; DivK1c_000578; SPECTRUM1503202; SPBio_000813; ZINC1131; CHEMBL1200596; DTXSID5022801; BDBM32147; CTK3J5578; HMS501M20; KBio1_000578; KBio2_001914; KBio2_004482; KBio2_007050; KBio3_002211; KS-00000FNW; NINDS_000578; HMS1923K05; HMS2092N04; HMS2609A16; HMS3259E17; HMS3655G16; HMS3712O06; Pharmakon1600-01503202; Capitrol Cream Shampoo (Salt/Mix); component of Capitrol Cream Shampoo; HY-B0295; NSC-3904; 5,7-Dichloro-8-quinolinol, 99%; Tox21_111494; ANW-37011; CCG-40039; NSC758398; s1839; SBB039926; STK075368; AKOS000271338; Tox21_111494_1; AC-4820; CS-2324; DB01243; MCULE-3987057340; NC00505; NSC-758398; RTR-024734; TRA0059012; IDI1_000578; UPCMLD0ENAT5752182:001; NCGC00095264-02; NCGC00095264-03; NCGC00095264-04; NCGC00095264-05; AK-89722; CPD000312779; SAM002554895; SC-75357; SMR000312779; SY016017; TG2-36-1; SBI-0051782.P002; AB2000325; LS-142531; TR-024734; A9795; D0412; FT-0623709; ST24029249; ST50160577; SW198618-2; D03472; AB00052323-08; AB00052323_09; AB00052323_10; SR-01000747474-2; SR-01000747474-3; W-104320; BRD-K17075857-001-06-9; Q12029435; F0918-0943; UNII-Z7Z4BX535U component WDFKMLRRRCGAKS-UHFFFAOYSA-N; Chloroxine; 5-21-03-00286 (Beilstein Handbook Reference)
Chlorpromazine 2-Chloro-N,N-dimethyl-10H-phenothiazine-10-propanamine; Chlorpromazine; Thorazine; Largactil; Contomin; Chloropromazine; 50-53-3; Chlorderazin; Aminazine; Chlorpromados; Fenactil; Megaphen; Propaphenin; 2-Chloropromazine; Aminazin; Ampliactil; Fenaktyl; Largactyl; Phenactyl; Promactil; Promazil; Psychozine; Sanopron; Torazina; Wintermin; Elmarin; Esmind; Prozil; Proma; Chlor-Promanyl; Largactilothiazine; Chlorpromazin; Clorpromazina; Novomazina; Fraction AB; Chlorpromazinum; 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine; Amplictil; SKF 2601-A; Cromedazine; Plegomasine; Aminasine; Amplicitil; HL 5746; Thorazine Suppositories; Clorpromazina [Italian]; BC 135; Chlor-PZ; CPZ; N-(3-Dimethylaminopropyl)-3-chlorophenothiazine; Chlorpromazinum [INN-Latin]; Clorpromazina [INN-Spanish]; 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-; Chlorpromazine Tannate; HSDB 3033; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine; 4560 R.P.; UNII-U42B7VYA4P; C17H19ClN2S; Propaphen; CCRIS 3711; CHEBI:3647; ZPEIMTDSQAKGNT-UHFFFAOYSA-N; 2-chloro-N,N-dimethyl-10H-Phenothiazine-10-propanamine; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina; CHEMBL71; EINECS 200-045-8; NSC 167745; 3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine; 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine; 2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine; Thorazine hydrochloride; U42B7VYA4P; 2-Cloro-10 (3-dimetilaminopropil)fenotiazina [Italian]; 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine; Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine [French]; Phenothiazine hydrochloride; Hibanil; Unitensen; NSC-167745; Phenothiazine, 2-chloro-10-(3-(dimethylamino)propyl)-; Phenothiazine, 2-chloro-10-[3-(dimethylamino)propyl]-; NCGC00015273-11; Chlordelazine; DSSTox_CID_2808; DSSTox_RID_76736; DSSTox_GSID_22808; 34468-21-8; 4560 Rp hydrochloride; [3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine; Prazilpromactil; Chlordelazin; Phenathyl; CAS-50-53-3; Thorazine (TN); Z80; NSC17479; Chlorpromazine [USAN:INN:BAN]; [3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine hydrochloride; NSC-226514; CAS-69-09-0; Chlorpromazine (USP/INN); Chlorpromazine cation radical; Chlropromados; Fraction; JHICC02042; Chlorpromazine [USP:INN:BAN]; SKF 2601A; SKF-2601; GG 407; Hibernal (Salt/Mix); Lomazine (Salt/Mix); Tranzine (Salt/Mix); Norcozine (Salt/Mix); Spectrum_000142; Prestwick0_000064; Prestwick1_000064; Prestwick2_000064; Prestwick3_000064; Spectrum2_001156; Spectrum3_000346; Spectrum4_000283; Spectrum5_000717; Lopac-C-8138; Biomol-NT_000020; Epitope ID:136898; GTPL83; 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, radical ion(1+); SCHEMBL8321; 10-(3-Dimethylaminopropyl)-2-chlorophenothiazine; 2-Chloro-10-(3-dimethylaminopropyl)phenothiazine; Lopac0_000249; Oprea1_110255; BSPBio_000247; BSPBio_002011; KBioGR_000806; KBioGR_002312; KBioSS_000622; KBioSS_002314; MLS003166901; DivK1c_000624; SPECTRUM1500184; 2-chloro-10-(3-(dimethylamino)propyl)-phenothiazine; SPBio_001111; SPBio_002168; BPBio1_000273; BPBio1_001181; QSPL 401; DTXSID0022808; CTK1C5154; HMS501P06; KBio1_000624; KBio2_000622; KBio2_002312; KBio2_003190; KBio2_004880; KBio2_005758; KBio2_007448; KBio3_001231; KBio3_002792; SKF-2601A; ZINC44027; cMAP_000017; NINDS_000624; Bio1_000457; Bio1_000946; Bio1_001435; HMS1920M03; HMS2089C12; HMS2091E06; HMS3430C19; KUC112482N; Pharmakon1600-01500184; ALBB-022464; BCP03610; KS-00002WW5; Tox21_110120; BBL028251; BDBM50001888; CCG-40059; NSC167745; NSC756689; s5749; STK182870; AKOS001490972; Tox21_110120_1; API0001970; DB00477; J2.794D; KS-5101; MCULE-5976054678; NSC-756689; RP-4560; SDCCGSBI-0050237.P005; IDI1_000624; QTL1_000021; NCGC00015273-01; NCGC00015273-02; NCGC00015273-03; NCGC00015273-04; NCGC00015273-05; NCGC00015273-06; NCGC00015273-07; NCGC00015273-08; NCGC00015273-09; NCGC00015273-10; NCGC00015273-12; NCGC00015273-13; NCGC00015273-14; NCGC00015273-15; NCGC00015273-16; NCGC00015273-17; NCGC00015273-19; NCGC00024409-04; NCGC00024409-05; NCGC00024409-06; NCGC00024409-07; NCGC00024409-08; 4560 R.P; KSC-315-032-; M176; SC-50091; SMR001453710; 2-chloro-10-[3-(dimethylamino)propyl]-; SBI-0050237.P004; AB0015094; AX8120990; LS-105361; WLN: T C666 BN ISJ B3N1&1 EG; 2601A; AB00051943; FT-0653683; R1242; 2601-A; C06906; D00270; J10069; M-1209; AB00051943-15; AB00051943-16; AB00051943_17; AB00051943_18; L000182; Q407972; SR-01000000012-5; SR-01000000012-6; 2-Chloro-10-(N-dimethylamino-n-propyl)-phenothiazine; BRD-K89997465-001-05-3; 1N,1N-dimethyl-3-(2-chloro-10H-10-phenothiazinyl)-1-propanamine; 3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine #; (chloropromazine) [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine; (chlorpromazine)[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine; [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine (chlor-promazine); [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine( Chlorpromazine); [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine(clorpromazine); Chlorpromazine; [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine; Chlorpromazine; 4560 R.P.
Chlorpropamide 4-Chloro-N-[(propylamino)carbonyl]benzenesulfonamide; chlorpropamide; 94-20-2; Chloropropamide; Diabinese; Chlorpropamid; Diabenese; Glucamide; Meldian; Chlorodiabina; Chloronase; Diabeneza; Diabetoral; Adiaben; Catanil; Diabaril; Dynalase; Insulase; Melitase; Diabechlor; Diabenal; Mellinese; Millinese; Asucrol; Glisema; Oradian; Diabet-Pages; Diamel Ex; Clorpropamid; Clorpropamide; Diabexan; Prodiaben; 1-(4-Chlorophenylsulfonyl)-3-propylurea; Chlorpropamidum; Clorpropamida; 4-chloro-N-(propylcarbamoyl)benzenesulfonamide; Bioglumin; 1-(p-Chlorobenzenesulfonyl)-3-propylurea; 1-Propyl-3-(p-chlorobenzenesulfonyl)urea; N-(4-Chlorophenylsulfonyl)-N'-propylurea; N-(p-Chlorobenzenesulfonyl)-N'-propylurea; N-Propyl-N'-(p-chlorobenzenesulfonyl)urea; Clorpropamide [DCIT]; Clorpropamide [Italian]; 4-chloro-N-[(propylamino)carbonyl]benzenesulfonamide; 1-(p-Chlorophenylsulfonyl)-3-propylurea; 1-p-Chlorophenyl-3-(propylsulfonyl)urea; NCI-C01752; Chlorpropamidum [INN-Latin]; Clorpropamida [INN-Spanish]; 4-Chloro-N-((propylamino)carbonyl)benzenesulfonamide; 1-(4-chlorophenyl)sulfonyl-3-propylurea; UNII-WTM2C3IL2X; N-Propyl-N'-p-chlorphenylsulfonylcarbamide; n-Propyl-N'-p-chlorophenylsulfonylcarbamide; P 607; NSC 44634; Benzenesulfonamide, 4-chloro-N-[(propylamino)carbonyl]-; CCRIS 155; U-9818; 1-(p-Chlorobenzensulfonyl)-3-propylurea; 4-Chloro-4-((propylamino)carbonyl)benzenesulfonamide; HSDB 2051; 1-((p-Chlorophenyl)sulfonyl)-3-propylurea; Benzenesulfonamide, 4-chloro-N-((propylamino)carbonyl)-; EINECS 202-314-5; U-3818; WTM2C3IL2X; CHEMBL498; NSC 626720; BRN 2218363; MLS000028395; CHEBI:3650; Insogen; Urea, 1-((p-chloropenyl)sulfonyl)-3-propyl-; RKWGIWYCVPQPMF-UHFFFAOYSA-N; Urea, 1-((p-chlorophenyl)sulfonyl)-3-propyl-; MFCD00079004; NSC626720; CAS-94-20-2; NCGC00015216-11; Chlorporpamide; SMR000058364; DSSTox_CID_322; chlorpropamide, alpha-form; 1-(4-chloro-benzenesulfonyl)-3-n-propyl-urea; Urea, 1-[(p-chlorophenyl)sulfonyl]-3-propyl-; chlorpropamide, epsilon-form; DSSTox_RID_75512; DSSTox_GSID_20322; chlorpropamide, epsilon-form; W-100205; dia benese; Diabinese (TN); Chlorpropamide [INN:BAN:JAN]; 4-chloro-n-(propylaminocarbonyl)benzenesulfonamide; SR-01000000060; CHLORPROPAMIDE USP; 4-chloro-N-((propylaminocarbonyl)benzenesulfonamide; N-[(4-chlorophenyl)sulfonyl](propylamino)carboxamide; 1-[(4-chlorobenzene)sulfonyl]-3-propylurea; Prestwick_684; Chlorpropamide [USP:INN:BAN:JAN]; Chlorpropamide B.P.; N3-Butyl-N1-p-chlorobenzenesulfonylurea; Spectrum_000144; N3-Butyl-N1-p-chlorobenzenesulfonylure a; ACMC-209rqj; 1-(4-chlorobenzenesulfonyl)-3-propylurea; 1-(4-chlorophenyl)sulfonyl-3-propyl-urea; Opera_ID_359; 1-(para-Chlorophenylsulfonyl)-3-propylurea; n-propyl-N'-p-chlorophenylsu lfonylcarbamide; Prestwick0_000323; Prestwick1_000323; Prestwick2_000323; Prestwick3_000323; Spectrum2_000089; Spectrum3_000347; Spectrum4_000284; Spectrum5_000719; WLN: GR DSWMVM3; Lopac-C-1290; chlorpropamide, delta-form; C 1290; Lopac0_000229; SCHEMBL23947; BSPBio_000325; BSPBio_002013; KBioGR_000808; KBioGR_002273; KBioSS_000624; KBioSS_002274; MLS001148665; DivK1c_000513; SPECTRUM1500185; SPBio_000018; SPBio_002246; BPBio1_000359; GTPL6801; DTXSID9020322; CTK8B2730; HMS501J15; KBio1_000513; KBio2_000624; KBio2_002273; KBio2_003192; KBio2_004841; KBio2_005760; KBio2_007409; KBio3_001233; KBio3_002753; KS-00000FWW; Chlorpropamide (JP17/USP/INN); cMAP_000007; NINDS_000513; HMS1569A07; HMS1920M05; HMS2091E08; HMS2096A07; HMS2233L19; HMS3259A17; HMS3260N19; HMS3373D09; HMS3428C03; HMS3652L03; HMS3713A07; Pharmakon1600-01500185; BCP09162; HY-B1429; NSC44634; ZINC1530599; Tox21_110102; Tox21_201391; Tox21_302789; Tox21_500229; ANW-40217; BDBM50344965; CCG-38905; GL6406; NSC-44634; NSC756690; s4166; SBB056923; STK857458; AKOS001482739; Tox21_110102_1; API0001972; CS-4917; DB00672; KS-5316; LP00229; LS-1959; MCULE-3261763364; NC00503; NSC-626720; NSC-756690; SDCCGSBI-0050217.P005; IDI1_000513; MRF-0000539; NCGC00015216-01; NCGC00015216-02; NCGC00015216-03; NCGC00015216-04; NCGC00015216-05; NCGC00015216-06; NCGC00015216-07; NCGC00015216-08; NCGC00015216-09; NCGC00015216-10; NCGC00015216-12; NCGC00015216-13; NCGC00015216-14; NCGC00015216-17; NCGC00015216-18; NCGC00021451-03; NCGC00021451-04; NCGC00021451-05; NCGC00021451-06; NCGC00021451-07; NCGC00021451-08; NCGC00256414-01; NCGC00258942-01; NCGC00260914-01; AK116029; CPD000058364; O227; SAM002554890; SC-75280; SY052508; SBI-0050217.P004; AX8120992; TC-128962; AB00051944; C1220; Chlorpropamide, analytical standard, >=97%; EU-0100229; P-607; ST24029048; ST50412138; SW196839-3; A16447; D00271; Urea, 1-propyl-3-(p-chloro-benzenesulfonyl)-; AB00051944_16; AB00051944_17; 4-Chloro-N-(propylcarbamoyl)benzene-1-sulfonamide; Q1075324; SR-01000000060-2; SR-01000000060-4; SR-01000000060-6; 4-Chloro-N-[(propylamino)-carbonyl]benzenesulfonamide; BRD-K97746869-001-05-6; BRD-K97746869-001-15-5; 1-Chloro-4-(([(propylamino)carbonyl]amino)sulfonyl)benzene #; Chlorpropamide, European Pharmacopoeia (EP) Reference Standard; Chlorpropamide, United States Pharmacopeia (USP) Reference Standard; Chlorpropamide, Pharmaceutical Secondary Standard; Certified Reference Material; Chloropropamide; P 607
Chlortetracycline (4S,4aS,5aS,6S,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide; Chlortetracycline; Acronize
Chlorthalidone 2-Chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide; chlorthalidone; Chlortalidone; 77-36-1; Phthalamudine; Chlorphthalidolone; Hygroton; Chlorthalidon; Phthalamodine; Chlorothalidone; Chlorphthalidone; Natriuran; Saluretin; Thalitone; Zambesil; Igroton; Isoren; Oradil; Renon; Hydro-Long; Oxodolin; Chlortalidonum; Famolin; Urolin; Oksodolin (oxodolin); Racemic chlorthalidone; (+-)-Hygroton; Clortalidone [DCIT]; (+-)-Chlorthalidone; Demi-Regroton; 2-Chloro-5-(1-hydroxy-3-oxoisoindolin-1-yl)benzenesulfonamide; Chlortalidonum [INN-Latin]; Clortalidona [INN-Spanish]; G-33182; 1-Keto-3-(3'-sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline; 2-Chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide; 3-Hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine; 3-(4'-Chloro-3'-sulfamoylphenyl)-3-hydroxyphthalimidine; 1-Oxo-3-(3-sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline; G 33182; C14H11ClN2O4S; HSDB 3035; EINECS 201-022-5; NSC 69200; NSC-69200; 2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide; Benzenesulfonamide, 2-chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)-; BRN 0312295; Benzenesulfonamide, 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-; MLS000069531; CHEBI:3654; Clortalidone; Higroton; JIVPVXMEBJLZRO-UHFFFAOYSA-N; 2-Chloro-5-(1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)benzenesulfonamide; 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide; Chlorthalidone, 98%; Clortalidona; Oxodoline; SMR000058635; DSSTox_CID_2812; 2-chloro-5-(1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)benzene-1-sulfonamide; DSSTox_RID_76738; DSSTox_GSID_22812; W-104322; Thalitone (TN); Hygroton (TN); Chlorthalidone (USP); Chlorthalidone [USAN:INN:BAN]; SR-01000721929; Chlortalidone (JAN/INN); Chlorthalidone [USAN:USP]; Oksodolin; CAS-77-36-1; NCGC00016317-01; Prestwick_759; Chlortalidone [INN]; Regroton (Salt/Mix); Combipres (Salt/Mix); Spectrum_000146; Opera_ID_138; (.+/-.)-Hygroton; Prestwick0_000351; Prestwick1_000351; Prestwick2_000351; Prestwick3_000351; Spectrum2_000099; Spectrum3_000349; Spectrum4_000957; Spectrum5_000743; (.+/-.)-Chlorthalidone; CHEMBL1055; SCHEMBL26234; BSPBio_000441; BSPBio_002017; KBioGR_001574; KBioSS_000626; 5-22-07-00602 (Beilstein Handbook Reference); Chlorthalidone (Chlortalidone); DivK1c_000731; SPECTRUM1500187; SPBio_000058; SPBio_002362; BPBio1_000487; GTPL7147; DTXSID4022812; BDBM25900; CTK8F8619; HMS502E13; KBio1_000731; KBio2_000626; KBio2_003194; KBio2_005762; KBio3_001237; KS-00000FWZ; NINDS_000731; HMS1569G03; HMS1920M09; HMS2091E12; HMS2096G03; HMS2236D07; HMS3259H04; HMS3372A07; HMS3713G03; Pharmakon1600-01500187; BCP27835; NSC69200; Tox21_110369; CCG-38917; NSC756692; s3074; STK686335; Chlortalidone 1.0 mg/ml in Methanol; AKOS005599810; Tox21_110369_1; API0001976; CS-2290; DB00310; KS-1342; MCULE-6661021422; NC00690; NSC-756692; VZ31574; IDI1_000731; NCGC00094616-01; NCGC00094616-02; NCGC00094616-03; NCGC00094616-04; NCGC00094616-07; AC-11367; AK116459; CC-25734; CPD000058635; H530; HY-15833; LS-31408; SAM002589983; ST088141; SBI-0051313.P003; AB0007445; AX8121003; DB-056211; ST2409846; 4CH-007156; AB00051946; FT-0602965; D00272; AB00051946_12; 036C257; C-20285; Q425289; SR-01000721929-2; SR-01000721929-3; BRD-A26384407-001-05-3; BRD-A26384407-001-15-2; 2-chloro-5-(1-hydroxy-3-oxoisoindolinyl)benzenesulfonamide; 2-Chloro-5(1-hydroxy-3-oxo-1-isoindolinyl) benzenesulfonamide; 2-Chloro-5-(1-hydroxy-3-oxo-1H-isoindolinyl)benzenesulfonamide; Chlorthalidone, European Pharmacopoeia (EP) Reference Standard; 2-chloro-5-(1,3-dihydroxy-1H-isoindol-1-yl)benzene-1-sulfonamide; Benzenesulfonamide,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-; Chlorthalidone, United States Pharmacopeia (USP) Reference Standard; 2-chloranyl-5-(1-oxidanyl-3-oxidanylidene-2H-isoindol-1-yl)benzenesulfonamide; 2-Chloro-5-(1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)benzenesulfonamide #; Chlortalidone for peak identification, European Pharmacopoeia (EP) Reference Standard; Chlorthalidone; G-33182
Cholesterol sulphate (3beta)-Cholest-5-en-3-ol hydrogen sulfate; Cholesteryl sulfate; CCRIS 7559
Cholic acid (3 alpha, 5 beta, 7 alpha, 12 alpha)-3,7,12-Trihydroxycholan-24-oic acid; Cholic acid; 4-10-00-02072 (Beilstein Handbook Reference)
Choline 2-Hydroxy-N,N,N-trimethylethanaminium; choline; Choline ion; Bilineurine; Choline cation; Cholinum; 2-Hydroxy-N,N,N-trimethylethanaminium; 62-49-7; (2-Hydroxyethyl)trimethylammonium; trimethylethanolamine; N-trimethylethanolamine; Ethanaminium, 2-hydroxy-N,N,N-trimethyl-; CCRIS 5847; AI3-24208; UNII-N91BDP6H0X; BRN 1736748; N,N,N-trimethylethanol-ammonium; CHEBI:15354; (beta-hydroxyethyl)trimethylammonium; EINECS 200-535-1; CHEMBL920; N91BDP6H0X; (2-hydroxyethyl)trimethylazanium; 2-hydroxy-N,N,N-trimethyl-ethanaminium; vitamin J; CHT; NSC402838; NCGC00015219-03; C5H14NO; 2-hydroxyethyl(trimethyl)azanium; 2-hydroxyethyl(trimethyl)ammonium; 1oba; 2reg; 3ppq; Choline (DCF); Choline (8CI); Spectrum_000258; 2ha3; 3r6u; Spectrum2_001938; Spectrum4_000867; Spectrum5_001579; Lopac-C-1754; bmse000285; bmse000953; bmse001003; Epitope ID:116046; SCHEMBL3142; Lopac0_000180; KBioGR_001533; KBioSS_000738; 24333-16-2; 3-04-00-00651 (Beilstein Handbook Reference); DivK1c_000107; 2-hydroxyethyl-trimethylazanium; N,N,N-trimethylethanolammonium; SPBio_001975; GTPL4551; DTXSID8043789; CTK5B5183; KBio1_000107; KBio2_000738; KBio2_003306; KBio2_005874; NSC6393; NINDS_000107; OEYIOHPDSNJKLS-UHFFFAOYSA-N; (2-Hydroxyethyl)trimethyl ammonium; mono-2-hydroxyethyltrimethylammonium; NSC-6393; ZINC3079337; BBL005532; BDBM50026220; MFCD00272239; STL137772; AKOS005721137; CCG-204275; DB00122; MCULE-7712564949; IDI1_000107; NCGC00015219-01; NCGC00015219-02; NCGC00015219-04; NCGC00162082-01; Ethanaminium,2-hydroxy-N,N,N-trimethyl-; LS-53167; SBI-0050168.P003; 2-Hydroxy-N,N,N-trimethylammonium chloride; 2-Hydroxy-N,N,N-trimethylethanaminium (Cl-); C00114; D07690; 11069-EP2269610A2; 11069-EP2269992A1; 11069-EP2270002A1; 11069-EP2270010A1; 11069-EP2272516A2; 11069-EP2272517A1; 11069-EP2272847A1; 11069-EP2272848A1; 11069-EP2275105A1; 11069-EP2277848A1; 11069-EP2277867A2; 11069-EP2280003A2; 11069-EP2281815A1; 11069-EP2284160A1; 11069-EP2284170A1; 11069-EP2284172A1; 11069-EP2289510A1; 11069-EP2289883A1; 11069-EP2289891A2; 11069-EP2289893A1; 11069-EP2295055A2; 11069-EP2295407A1; 11069-EP2295409A1; 11069-EP2295418A1; 11069-EP2295433A2; 11069-EP2298312A1; 11069-EP2298736A1; 11069-EP2298742A1; 11069-EP2298743A1; 11069-EP2298744A2; 11069-EP2298755A1; 11069-EP2298758A1; 11069-EP2298759A1; 11069-EP2298768A1; 11069-EP2298770A1; 11069-EP2301933A1; 11069-EP2301937A1; 11069-EP2305250A1; 11069-EP2305640A2; 11069-EP2305642A2; 11069-EP2305664A1; 11069-EP2305671A1; 11069-EP2305675A1; 11069-EP2305677A1; 11069-EP2305682A1; 11069-EP2308840A1; 11069-EP2308841A2; 11069-EP2308848A1; 11069-EP2308879A1; 11069-EP2311453A1; 11069-EP2311827A1; 11069-EP2311835A1; 11069-EP2311842A2; 11069-EP2314295A1; 11069-EP2314583A1; 11069-EP2314584A1; 11069-EP2314585A1; 11069-EP2314588A1; 11069-EP2314590A1; 11069-EP2314593A1; 11069-EP2316457A1; 11069-EP2316458A1; 11069-EP2316825A1; 11069-EP2316826A1; 11069-EP2316827A1; 11069-EP2316828A1; AB00053822_02; Ethanaminium, 2-hydroxy-N,N,N-trimethyl- (9CI); Q193166; InChI=1/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+; Choline; 3-04-00-00651 (Beilstein Handbook Reference)
Chromium chloride (CrCl3) Chromic chloride; C.I. 77295
Chromomycin a3 (1S)-1-C-[(2S,3S)-7-[[4-O-Acetyl-2,6-dideoxy-3-O-(2,6-dideoxy-4-O-methyl-alpha-D-lyxo-hexopyranosyl)-beta-D-lyxo-hexopyranosyl]oxy]-3-[[O-4-O-acetyl-2,6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl-(1->3)-O-2,6-dideoxy-beta-D-arabino-hexopyranosyl-(1->3)-2,6-dideoxy-beta-D-arabino-hexopyranosyl]oxy]-1,2,3,4-tetrahydro-5,10-dihydroxy-6-methyl-4-oxo-2-anthracenyl]-5-deoxy-1-O-methyl-D-threo-2-pentulose; Chromomycin A3; Aburamycin B
Ciglitazone 5-[[4-[(1-Methylcyclohexyl)methoxy]phenyl]methyl]-2,4-thiazolidinedione; ciglitazone; 74772-77-3; Ciglitizone; ADD-3878; CiglitazoCiglitazonum; Ciglitazonum [Latin]; Ciglitazona [Spanish]; Ciglitazone [USAN:INN]; ADD 3878; 5-(4-((1-methylcyclohexyl)methoxy)benzyl)thiazolidine-2,4-dione; CHEBI:64227; U-63287; (+-)-5-(p-((1-Methylcyclohexyl)methoxy)benzyl)-2,4-thiazolidinedione; C18H23NO3S; YZFWTZACSRHJQD-UHFFFAOYSA-N; (+/-)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione; 5-{4-[(1-methylcyclohexyl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione; U 63287; NCGC00164446-01; DSSTox_CID_20757; DSSTox_RID_79589; DSSTox_GSID_40757; 5-[[4-[(1-Methylcyclohexyl)methoxy]phenyl]methyl]-2,4-thiazolidinedione; 2,4-Thiazolidinedione, 5-((4-((1-methylcyclohexyl)methoxy)phenyl)methyl)-, (+-)-; CAS-74772-77-3; SR-01000597400; 2,4-Thiazolidinedione, 5-((4-((1-methylcyclohexyl)methoxy)phenyl)methyl)-; 2,4-Thiazolidinedione, 5-[[4-[(1-methylcyclohexyl)methoxy]phenyl]methyl]-; MFCD00865499; ACMC-20emv7; Spectrum5_001949; Ciglitazone (USAN/INN); UPCMLD-DP145; CBiol_001858; SCHEMBL38185; BSPBio_001575; KBioGR_000295; KBioSS_000295; BML2-F01; GTPL2711; DTXSID0040757; UPCMLD-DP145:001; UPCMLD-DP145:002; BCBcMAP01_000122; Ciglitizone, >=98% (HPLC); CTK7H5565; KBio2_000295; KBio2_002863; KBio2_005431; KBio3_000589; KBio3_000590; Bio1_000144; Bio1_000633; Bio1_001122; Bio2_000295; Bio2_000775; HMS1361O17; HMS1791O17; HMS1989O17; HMS3267N05; HMS3402O17; HMS3412E22; HMS3649G06; HMS3676E22; 5-(4-(1-methylcyclohexylmethoxy)benzyl)thiazolidine-2,4-dione; Tox21 112120; Tox21_112120; BDBM50103636; GL8018; AKOS000278268; AKOS024257650; Tox21_112120_1; API0002009; CS-W011936; DB09201; MCULE-4419123362; TRA0078629; 5-[[4-[(1-methylcyclohexyl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; IDI1_034045; KS-0000008X; NCGC00025104-02; NCGC00025104-03; NCGC00025104-04; NCGC00025104-05; NCGC00025104-07; NCGC00025104-08; NCGC00025104-09; AS-56269; CC-25778; SC-50312; ST079285; ZINC000001481754; DB-055908; LS-151334; TX-017480; FT-0602959; Z3112; D03493; C-20127; Q5119890; SR-01000597400-1; SR-01000597400-3; SR-01000597400-4; BRD-A93000692-001-02-4; BRD-A93000692-001-03-2; 5-[4-(1-methylcyclohexylmethyloxy)benzyl]thiazolidine-2,4-dione; 5-((4-((1-methylcyclohexyl)methoxy)phenyl)methyl)-4-thiazolidinedione; 5-({4-[(methylcyclohexyl)methoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione; LO4; Ciglitazone; U 63287
Ciloxan 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid monohydrochloride, Monohydrate; Ciprofloxacin hydrochloride [USAN:USP:JAN]; Ciloxan
Cimetidine N-Cyano-N'-methyl-N''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]guanidine; cimetidine; 51481-61-9; Tagamet; Eureceptor; Tametin; Dyspamet; Ulcedine; Acinil; Cimetag; Tratul; Ulcedin; Acibilin; Gastromet; Cimetum; Edalene; Ulcimet; Ulcomet; Cimal; Ulhys; Tagamet Hb; Cimetidine Hcl; Tagamet Hb 200; CimetidiUlcomediMetracin; Valmagen; SKF-92334; Cimetidinum; Gastrobitan; Ulcestop; Ulcofalk; Evicer; Peptol; SKF 92334; Cimetidinum [INN-Latin]; Cimetidina [INN-Spanish]; 2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine; DRG-0150; 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine; Cimetidine, A Type; UNII-80061L1WGD; N-Cyano-N'-methyl-N''-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]guanidine; CCRIS 3247; CHEBI:3699; HSDB 3917; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; FPF 1002; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; CHEMBL30; EINECS 257-232-2; NSC-335308; Brumetadi2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; MLS000069791; Altramet; C10H16N6S; AQIXAKUUQRKLND-UHFFFAOYSA-N; 80061L1WGD; Guanidine, N-cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)-; Guanidine, N-cyano-N'-methyl-N''-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]-; NCGC00015240-06; Sigmetadine; Histodil; Magicul; SMR000038895; Venopex; DSSTox_CID_329; 2-cyano-1-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; DSSTox_RID_75517; Guanidine, N-cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio) ethyl)-; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N-cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine; DSSTox_GSID_20329; Biomet400; BrumetidiCimetadine; Ci metum; (E)-2-cyano-1-methyl-3-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine; 1-cyano-2-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-cyano-1-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; Guanidine, N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)-; Guanidine, N''-cyano-N-methyl-N'-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]-; N-cyano-N'-methyl-N''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; 2984-61-4; Tagamet (TN); Equaline acid reducer; Topcare heartburn relief; Cimetidine [USAN:INN:BAN:JAN]; SR-01000075260; SR-05000001434; SK&F-92334; cemitidine; metidine; 1-cyano-2-methyl-3-(2-((5-methyl-1H-imidazol-4-yl)methylthio)ethyl)guanidine; 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; Cimetidine,(S); Prestwick_65; {(1E)-1-(methylamino)-4-[(4-methylimidazol-5-yl)methylthio]-2-azabut-1-enyl}am inocarbonitrile; MFCD00133296; Cimetidine (Tagamet); Cimetidine [USAN:USP:INN:BAN:JAN]; CIMETIDINE A; Spectrum_000495; Tocris-0902; Opera_ID_314; Prestwick3_000026; Spectrum2_000782; Spectrum3_001389; Spectrum4_000812; Spectrum5_001541; Lopac-C-4522; UPCMLD-DP029; C 4522; SCHEMBL1093; SCHEMBL1094; SKF-92334; Tagamet; Lopac0_000293; BSPBio_000091; BSPBio_002978; KBioGR_001323; KBioSS_000975; US9138393, Cimetidine; US9144538, Cimetidine; 76181-71-0; MLS001148596; MLS002153265; MLS002154178; DivK1c_000166; SPECTRUM1500684; SPBio_000884; BPBio1_000101; Cimetidine (JP17/USP/INN); GTPL1231; DTXSID4020329; SCHEMBL11282982; UPCMLD-DP029:001; BDBM22889; HMS500I08; KBio1_000166; KBio2_000975; KBio2_003543; KBio2_006111; KBio3_002198; NINDS_000166; BDBM181119; HMS1921C14; HMS2089O03; HMS2092I14; HMS2095E13; HMS2232F16; HMS3259M15; HMS3260L08; HMS3267A03; HMS3369L10; HMS3414I17; HMS3651E21; HMS3678I17; HMS3712E13; HMS3750I05; Pharmakon1600-01500684; Cimetidine 1.0 mg/ml in Methanol; EX-A1088; Tox21_110106; Tox21_201160; Tox21_500293; ANW-46065; BDBM50103595; BDBM50403559; CCG-40160; NSC335308; NSC757428; s1845; SBB057794; STK528249; ZINC18115268; 1-Cyano-2-methyl-3-[2-[[(5-methylimidazol-4-yl)methyl]thio]ethyl]guanidine; AKOS005460997; AKOS015900557; AKOS015951369; AKOS016003398; AKOS016340377; AKOS026749950; AKOS032949548; Tox21_110106_1; AB03708; AC-8100; CCG-204388; CCG-220026; CCG-221597; CS-2325; DB00501; KS-5087; LP00293; LS-7278; MCULE-2885245608; NC00501; NSC 335308; NSC-757428; SDCCGSBI-0050281.P005; IDI1_000166; N''-cyano-N-methyl-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)-ethyl)guanidine; N''-Cyano-N-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine; N-Cyano-N'-methyl-[2-[[[5-methyl-1H-imidazol-4-yl]methyl]thio]ethyl]guanidine; N-Cyano-N'-methyl-N''-(2-(((5-methyl-1 H-imidazol-4-yl) methyl)thio)ethyl)guanidine; NCGC00015240-01; NCGC00015240-02; NCGC00015240-03; NCGC00015240-04; NCGC00015240-05; NCGC00015240-07; NCGC00024859-01; NCGC00024859-02; NCGC00024859-03; NCGC00024859-04; NCGC00024859-05; NCGC00091439-01; NCGC00091439-02; NCGC00091439-03; NCGC00091439-04; NCGC00091439-05; NCGC00091439-07; NCGC00185989-01; NCGC00188961-01; NCGC00258712-01; NCGC00260978-01; AK-77142; CPD001370748; H505; HY-14289; LS-73445; LS-73446; NCI60_002936; SAM002554892; SC-15209; SBI-0050281.P004; AB0013083; AB1009523; DB-051971; TC-134810; EU-0100293; FT-0602955; ST24048532; ST50411770; SW196380-2; A10218; C06952; D00295; J10340; M-1577; AB00052157-03; AB00052157_04; AB00052157_05; 481C619; A828616; L000186; L003827; L013434; Q409492; SR-05000001750; Q-200855; Q-200856; SR-01000075260-1; SR-01000075260-3; SR-05000001434-1; SR-05000001434-2; SR-05000001750-1; BRD-K18618618-001-01-6; BRD-K34157611-001-04-6; BRD-K34157611-001-07-9; Z1259192068; Cimetidine, European Pharmacopoeia (EP) Reference Standard; 4H -Dithieno[3,2-b :2',3'-d ]pyrrole, 4-(1-octylnonyl)-; Cimetidine, United States Pharmacopeia (USP) Reference Standard; 1-Ethyl-2,3-dimethylimidazolium tosylate, 98% [EDiMIM] [TOS]; 1-Cyan-2-methyl-3-(2-{[(5-methylimidazol-4-yl)methyl]thio}ethyl)guanidin; Cimetidine, Pharmaceutical Secondary Standard; Certified Reference Material; N"-cyano-N-methyl-N'-[2-(5-methylimidazol-4-ylmethylthio)ethyl]-guanidine; N"-cyano-N-methyl-N'-[2-(5-methylimidazol-4-ylmethylthio)ethyl]guanidine; N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)methylthio)ethyl]guanidine; N-cyano-N'-methyl-N"-[2-((5-methyl-4-imidazolyl)methylthio)ethyl]guanidine; N-cyano-N'-methyl-N"-[2-(5-methyl-4-imidazolylmethylthio)ethyl]guanidine; (Z)-1-cyano-2-methyl-3-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; 2-Chloro-5-(1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)-benzenesulfonamide(Cimetidine); 2-Methyl-8-phenethyl-imidazo[1,2-a]pyridine-3-carboxylic acid methyl ester(cimetidine); 2-methylamino-2-[2-(4-methyl-1H-5-imidazolylmethylsulfanyl)ethylamino]-(E)-1-imino cyanide; 3-cyano-2-methyl-1-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine; 4-(((2-(((cyanoamino)(methylamino)methylene)amino)ethyl)thio)methyl)-5-methyl-1H-imidazole; Cimetidine for peak identification, European Pharmacopoeia (EP) Reference Standard; Cimetidine for system suitability, European Pharmacopoeia (EP) Reference Standard; Guanidine, N-cyano-N'-methyl-N''-[2-[[5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]-; N''-cyano-N-methyl-N'-(2-((5-methyl-1h-imidazol-4-yl)-methylthio)ethyl)guanidine; N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine; N-cyano-N'-methyl-N"- [2-((5-methyl-4-imidazolyl)methylthio)ethyl]guanidine; N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl) methylthio)ethyl]guanidine; N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)- methylthio)ethyl]guanidine; N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)-methylthio)ethyl]guanidine; N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)methyl-thio)ethyl]guanidine; N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)methylthio)ethyl) guanidine; N-cyano-N'-methyl-N"-[2-((5-methyl-4-imidazolyl)methylthio)-ethyl]guanidine; N-cyano-N'-methyl-N"-[2-((5-methyl-4-imidazolyl)methylthio)ethyl]-guanidine; N-cyano-N'-methyl-N"-[2-{(5-methyl-1H-imidazol-4-yl)methylthio}ethyl]guanidine; N-Cyano-N'-methyl-N''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine #; N-Cyano-N'-methyl-N''-[2-[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine; N-cyano-N'-methyl-N''-[2-[[(5-methylimidazol-4-yl]methyl]thio]ethyl)guanidine; N-cyano-N'-methyl-N-"-[2-((4-methyl-5-imidazolyl)methylthio)ethyl]guanidine; N-methyl-N'-{2-[(5-methylimidazol-4-yl)-methylthio]-ethyl}-N"-cyanoguanidine; N-methyl-N-[2-(5-methyl-1H-4-imidazolylmethylsulfanyl)ethyl]-1-cyanoiminomethanediamine; N-methyl-N-[2-(5-methyl-1H-4-imidazolylmethylsulfanyl)ethyl]imino(-N-cyano)methanediaminem; N-tert-Butyl-N''''''''-[4-(1H-imidazol-4-yl)-phenyl]-formamidine(cimetidine); (Cimetidine) N-Methyl-N''''''''-[2-(5-methyl-1H-imidazol-4-ylmethylsulfanyl)-ethyl]-guanidine,cyanide; (cimetidine) N-methyl-N-[2-(5-methyl-1H-4-imidazolylmethylsulfanyl)ethyl]cyanoiminomethanediamine; (Cimetidine)N-methyl-N-[2-(5-methyl-1H-4-imidazolylmethylsulfanyl)ethyl]cyanomethyliminomethanediamine; 2-methylamino-2-[2-(5-methyl-1H-4-imidazolylmethylsulfanyl)ethylamino]-(Z)-1-imino cyanide(cimetidine); 943920-67-0; Guanidine,N-cyano-N'-Methyl-N''-[2-[[(5-Methyl-1H-iMidazol-4-yl)Methyl]thio]ethyl]-,(Z)-; N''''''''''''''''''''''''''''''''-cyano-N-methyl-N''''''''''''''''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N''''''''''''''''-cyano-N-methyl-N''''''''-({[(5-methyl-1H-imidazol-4-yl)methyl]thio}methyl)guanidine(cimetidine); N''''''''''''''''-cyano-N-methyl-N''''''''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]-lambda~4~-sulfanyl}ethyl)guanidine; N''''''''''''''''-cyano-N-methyl-N''''''''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine; N''''''''''''''''-cyano-N-methyl-N''''''''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine (Cimetidine); N''''''''''''''''-cyano-N-methyl-N''''''''-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine(cimetidine); N-Cyano-N''''''''-methyl-N''''''''''''''''-(2-(((5-methyl-1H-imidazol-4-yl) methyl)thio)ethyl)guanidine(Cimetidine); N-cyanomethyl-N''''''''-methyl-N''''''''''''''''-[2-(5-methyl-1H-imidazol-4-ylmethylsulfanyl)-ethyl]-guanidine ( Cimetidine); N-Methyl-N''''''''-[2-(5-methyl-1H-imidazol-4-ylmethylsulfanyl)-ethyl]-cyanoguanidine(cimetidine); N-Methyl-N''''''''-[2-(5-methyl-1H-imidazol-4-ylmethylsulfanyl)-ethyl]-N''''''''''''''''-Cyano-guanidine; N-Methyl-N''''''''-[2-(5-methyl-1H-imidazol-4-ylmethylsulfanyl)-ethyl]-N''''''''''''''''-cyano-guanidine(Cimetidine); N-methyl-N''''''''-cyano-N''''''''''''''''-[2-(5-methyl-1H-imidazol-4-ylmethylsulfanyl)-ethyl]-guanidine; N-methyl-N-[2-(5-methyl-1H-4-imidazolylmethylsulfanyl)ethyl]cyanoiminomethanediamine (cimetidine); Cimetidine; Acibilin
Ciprofloxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid; Ciprofloxacin; BRN 3568352
Cirazoline 2-[(2-Cyclopropylphenoxy)methyl]-4,5-dihydro-1H-imidazole; cirazoline; Cirazoline [INN]; 59939-16-1; Cirazolinum [INN-Latin]; Cirazolina [INN-Spanish]; UNII-QK318GVY3Y; LD-3098; QK318GVY3Y; CHEMBL13852; NCGC00015196-04; 2-((o-Cyclopropylphenoxy)methyl)-2-imidazoline; DSSTox_CID_25131; DSSTox_RID_80692; DSSTox_GSID_45131; CirazoliCirazolinum; 1H-Imidazole, 2-((2-cyclopropylphenoxy)methyl)-4,5-dihydro-; CAS-59939-16-1; LD 3098; Tocris-0888; Lopac-C-223; Lopac0_000354; BSPBio_001586; GTPL515; KBioGR_000306; KBioSS_000306; SCHEMBL126496; ZINC1160; 2-(2'-cyclopropylphenoxymethyl)imidazoline hydrochloride; DTXSID4045131; CHEBI:92950; KBio2_000306; KBio2_002874; KBio2_005442; KBio3_000611; KBio3_000612; 2-[(2-cyclopropylphenoxy)methyl]-4,5-dihydro-1H-imidazole; Bio1_000412; Bio1_000901; Bio1_001390; Bio2_000306; Bio2_000786; HMS1361P08; HMS1791P08; HMS1989P08; HMS2089E21; HMS3402P08; Tox21_110095; BDBM50027060; Tox21_110095_1; CCG-204449; DB09202; SDCCGSBI-0050342.P002; 1H-Imidazole, 2-((2-cyclopropylphenoxy)methyl)-4,5-dihydro-, monohydrochloride; IDI1_034056; NCGC00015196-01; NCGC00015196-02; NCGC00015196-03; NCGC00015196-05; NCGC00015196-06; NCGC00015196-07; NCGC00015196-08; NCGC00015196-09; NCGC00024847-01; NCGC00024847-02; NCGC00024847-03; NCGC00024847-04; NCGC00024847-05; LS-78346; DB-053499; FT-0602943; C-15616; L000800; Q5121338; BRD-K54142781-001-02-1; BRD-K54142781-003-02-7; BRD-K54142781-003-08-4; 2-(2-Cyclopropyl-phenoxymethyl)-4,5-dihydro-1H-imidazole; 2-(2-Cyclopropyl-phenoxymethyl)-4,5-dihydro-1H-imidazole (cirazoline); Cirazoline; Cirazolina [INN-Spanish]
Citraconic acid (2Z)-2-Methyl-2-butenedioic acid; Citraconic acid; 4-02-00-02230 (Beilstein Handbook Reference)
Citrulline N5-(Aminocarbonyl)-L-ornithine; L-citrulline; citrulline; 372-75-8; H-cit-oh; delta-Ureidonorvaline; Sitrulline; N5-Carbamoyl-L-ornithine; L-Cytrulline; N(delta)-Carbamylornithine; L(+)-citrulline; N5-(Aminocarbonyl)ornithine; Citrulline, L-; alpha-Amino-delta-ureidovaleric acid; (S)-2-Amino-5-ureidopentanoic acid; N5-carbamoylornithine; Ornithine, N5-(aminocarbonyl)-; 2-Amino-5-ureidovaleric acid; L-2-Amino-5-ureidovaleric acid; L-(+)-Citrulline; L-Ornithine, N5-(aminocarbonyl)-; L-citrullin; (2S)-2-amino-5-(carbamoylamino)pentanoic acid; UNII-29VT07BGDA; N5-(Aminocarbonyl)-L-ornithine; EINECS 206-759-6; MFCD00064397; NSC 27425; 29VT07BGDA; N~5~-carbamoyl-L-ornithine; CHEBI:16349; RHGKLRLOHDJJDR-BYPYZUCNSA-N; N(5)-(aminocarbonyl)-L-ornithine; cit; Ornithine, N5-carbamoyl-, L- (8CI); d-ureidonorvaline; L(+)-Citrulline, 99%; 2-Amino-5-uredovaleric acid; (2S)-2-amino-5-(aminocarbonylamino)pentanoic acid; CIR; Ngamma-carbamylornithine; W-202536; L-Citruline; N5-carbamylornithine; alpha-amino-gamma-ureidovaleric acid; Cytrulline; Ureidonorvaline; Ureidovalerate; H-Orn(carbamoyl)-OH; L-Citrulline; gammaureidonorvaline; N-carbamylornithine; L-Citrulline, 4; AK-81236; Amino-ureidovalerate; ND-carbamylornithine; L-Citrulline,(S); L(+)-Citrulline; N()-carbamylornithine; L-Citrulline (DCF); Ndelta-Carbamylornithine; Amino-ureidovaleric acid; Ndelta-carbamy-ornithine; A-amino-d-ureidovalerate; 2-Amino-5-uredovalerate; 2-Amino-5-ureidovalerate; L-N5-carbamoyl-Ornithine; bmse000032; bmse000800; bmse000858; A-amino-d-ureidovaleric acid; L-2-Amino-5-ureidovalerate; N(5)-carbamoyl-L-ornithine; SCHEMBL20588; GTPL722; KSC491O9P; N5-(aminocarbonyl)-Ornithine; L-2-Amino-5-ureido-valerate; CHEMBL444814; Alpha-amino-delta-ureidovalerate; Alpha-amino-gamma-ureidovalerate; Ornithine, N5-carbamoyl-, L-; SCHEMBL13254095; BDBM92903; CTK3J1797; KS-00000ALZ; (S)-2-Amino-5-ureidopentanoate; DTXSID80883373; L(+)-2-Amino-5-ureidovalerate; L-2-Amino-5-ureido-valeric acid; L-Citrulline, >=98% (TLC); HY-N0391; ZINC1532614; ANW-28607; GM7920; L(+)-2-Amino-5-ureidovaleric acid; s3798; SBB012374; AKOS005259571; AKOS006240677; L-(+)-2-Amino-5-ureidovaleric acid; AM82461; CS-W019940; DB00155; RTR-036630; SMP1_000146; NCGC00142602-01; AC-23976; AS-12594; CC-29878; SC-10123; ST069317; (2S)-2-amino-5-(carbamoylamino)pentanoate; AB1002637; AX8008670; BB0295778; LS-185994; ST2407065; TR-036630; FT-0627745; (S)-2-amino-5-(aminocarbonyl)aminopentanoate; C00327; D07706; K-8238; (S)-2-amino-5-(aminocarbonyl)aminopentanoic acid; 372C758; C-06018; Q408641; EA65B21D-61C4-4748-9E9F-0CF6EDF9A21D; UNII-1OYO2NV4NM component RHGKLRLOHDJJDR-BYPYZUCNSA-N; (2S)-2-Amino-5-(carbamoylamino)pentanoic Acid (Citrulline); (S)-2-Amino-5-ureidopentanoic acid; L-2-Amino-5-ureidovaleric acid; L-Citrulline, United States Pharmacopeia (USP) Reference Standard; N5-(Aminocarbonyl)ornithine; alpha-Amino-delta-ureidovaleric acid
Clarithromycin 6-O-Methylerythromycin; clarithromycin; 81103-11-9; Biaxin; 6-O-Methylerythromycin; Klaricid; 6-O-Methylerythromycin a; Clarithromycine; Clathromycin; Abbott-56268; Macladin; Clarith; Klacid; Kofron; Veclam; Clarithromycinum; Naxy; A-56268; Erythromycin, 6-O-methyl-; Biaxin XL; TE-031; Abbotic; Astromen; Bicrolid; Clacine; Clambiotic; Claribid; Claricide; Claridar; Claripen; Fromilid; Heliclar; Klaciped; Mabicrol; Clacee; Clacid; Clarem; Crixan; Cyllid; Klabax; Klarid; Klarin; Maclar; Zeclar; Helas; Mavid; Adel; Biaxin filmtab; Klax; Biaxin HP; Biaxin xl filmtab; Klaricid Pediatric; DRG-0099; UNII-H1250JIK0A; Clarithromycine [INN-French]; Clarithromycinum [INN-Latin]; Claritromicina [INN-Spanish]; Prevpac; CHEBI:3732; H1250JIK0A; C38H69NO13; ClaritromiciCPD000466382; CLA; Clarithromycin extended release; Clari; Infex; Vikrol; Klaricid H.P.; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione; CTY; SMR000466382; SR-05000001992; Clarithromycin (Biaxin, Klacid); clarithromyciCyllind; CCRIS 8833; Klaricid XL; HSDB 8055; (14R)-14-Hydroxyclarithromycin; Klaricid H.P; TE031; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy; Clarithromycin,(S); Biaxin (TN); Clarithromycin [USAN:INN:BAN:JAN]; Clarithromycin identity; Clarithromycin, 97%; Spectrum_000089; Clarithromycin [USAN:USP:INN:BAN:JAN]; SpecPlus_000559; 6-O-methyl erythromycin; O(6)-methylerythromycin; CLA; Spectrum2_001668; Spectrum3_001667; Spectrum4_000629; Spectrum5_001729; 6-0-methylerythromycin A; CHEMBL1741; SCHEMBL38125; BSPBio_003453; KBioGR_001218; KBioSS_000509; MLS000759516; MLS001201751; MLS001424066; BIDD:GT0200; DivK1c_006655; SPECTRUM1504231; SPBio_001855; Lactoferrin B & Clarithromycin; Lactoferrin H & Clarithromycin; DTXSID3022829; Clarithromycin & Interleukin-12; CLM & IL-12; KBio1_001599; KBio2_000509; KBio2_003077; KBio2_005645; KBio3_002673; ANX-015; SDP-015; AGOYDEPGAOXOCK-KCBOHYOISA-N; Clarithromycin (JP17/USP/INN); Clarithromycin, >=95% (HPLC); Clarithromycin, >=98% (HPLC); HMS1922H09; HMS2051G18; HMS2090O11; HMS2094M05; HMS2231A08; HMS3715J17; Pharmakon1600-01504231; Clarithromycin suspension or tablets; EBD13493; BDBM50404044; CCG-39086; LMPK04000014; MFCD00865140; NSC758704; s2555; ZINC85534098; C30H54O11.C9H19NO2; AKOS015894242; CS-2576; DB01211; LS-1812; MCULE-7168853332; NC00140; NSC-758704; NCGC00178054-01; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione; CC-25899; H781; HY-17508; SAM001246748; SBI-0206716.P001; FT-0602940; C06912; D00276; J10130; AB00053394-10; AB00053394-12; AB00053394-13; AB00053394_14; AB00053394_15; 103C119; C-23486; Q118551; Q-200870; SR-05000001992-1; SR-05000001992-2; BRD-K49668410-001-07-1; BRD-K49668410-001-18-8; Clarithromycin, European Pharmacopoeia (EP) Reference Standard; Clarithromycin, United States Pharmacopeia (USP) Reference Standard; Clarithromycin Identity, United States Pharmacopeia (USP) Reference Standard; Clarithromycin, Ready Made Solution, 50 mg/mL in DMSO, 0.2 mum filtered; Clarithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard; Clarithromycin, Pharmaceutical Secondary Standard; Certified Reference Material; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name); (3R,4S,5S,6R,7R,9R,11S, 12R,13S,14S)-6-{[(2S,3R,4S,6R)- 4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-12,13-dihydroxy- 4-{[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-4,6- dimethyloxan-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyl-1- oxacyclotetradecane-2,10-dione; (3R,4S,5S,6R,7S,9R,11R,12R,13R,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione; 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione; Clarithromycin; A-56268
Clavamox (2R,3Z,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid potassium salt (1:1) mixt. with (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Amoxicillin-potassium clavulanate combination; Amoxicillin mixed with potassium clavulanate (2:1)